- Entry
- $12.00
- Now
- $12.00 +0.0%
- Target
- —
- Score
- —
Are there other investors in CMPS here? Comp360 is proprietary psilocybin, that’s being studied in treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Comp360 looks to be the first psychedelic to market. Their phase 3 studies (comp005 and comp006) in TRD are done, and they have been already doing rolling NDA for FDA. They guide to finalize their NDA (New Drug Application) in q4. I have reasons to believe the NDA will be submitting already in this month, because otherwise …
— ORIGINAL POST ·
Compass Pathways (CMPS)-first FDA-approved psychedelic to market
· r/pennystocks
· Oct 9, 2026